Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pneusomnia is a branded network of multidisciplinary sleep clinics focused on the diagnosis and treatment of obstructive sleep apnea and related sleep-disordered breathing conditions. The clinics emphasize holistic, continuity-of-care management and offer a mix of diagnostic services and non-drug interventions, including home sleep testing, PAP optimization, mandibular advancement devices, oral myofunctional therapy, minimally invasive procedures, and Vivos-associated airway treatment approaches. Public materials indicate that Pneusomnia centers are clinician-owned or independent practices operating under the Pneusomnia brand rather than a standalone drug-development biotech company. The brand appears closely associated with Vivos Therapeutics' medical integration efforts and sleep-center expansion strategy. Overall, this is a commercial healthcare delivery entity in sleep medicine, not a therapeutic R&D company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pneusomnia.